PATIENTS AND METHODS
A list sorted according to date of examination of 7922 patients who underwent ultrasound scanning between May 1998 and May 2000 was compiled. Pages of this list were then selected in no particular order by two of the authors for evaluation. All patients listed on each of the pages selected for evaluation were included in the analysis with the following exception: patients with multiple scans were only evaluated per their initial scan. Medical records from a total of 1080 patients were retrospectively reviewed to collect data on patient age, sex, comorbidity, and reason for ultrasound scan The results were then compiled and entered into an SPSS 10.0 (SPSS, Inc, Chicago, Ill) data file.
The duplex ultrasound scan was performed from the level of the groin to the ankle in all symptomatic extremities. In the asymptomatic extremity, ultrasound scan from the groin to the ankle was performed in 90% of patients. The remaining 10% did not undergo evaluation of the calf venous system secondary to the presence of dressings, wounds, or sequential compression stockings on that extremity.
Compression ultrasound scanning with spectral analysis and color-flow Doppler has become the test of choice to diagnose symptomatic deep venous thrombosis (DVT). In our institution, this test has been performed bilaterally even when patients have symptoms confined to one limb. Traditionally, venography has usually been limited to the symptomatic limb, because the presence of bilateral DVT will rarely change therapy and most surgeons feel that an invasive test on an extremity that is asymptomatic is not warranted.
In an attempt to optimize the use of ultrasound scanning as it relates to the diagnosis of DVT, some authors have proposed studying only the symptomatic extremity. [1] [2] [3] [4] [5] Others have disagreed, citing a significant frequency of bilateral thrombotic events and the occasional contralateral thrombotic event in this patient population. [6] [7] [8] We believe there is a role for limiting the examination to the All duplex scans were performed with either a 3000 HDI or 5000 HDI ultrasound machine (Advanced Technology Laboratories, Bothell, Wash). All machines were equipped with color Doppler and the appropriate 5-MHz, 7-MHz, or 10-MHz linear array transducers. The examinations were performed in an Intersocietal Commission for Accreditation of Vascular Laboratoriesapproved vascular laboratory. Examination included grayscale, color Doppler, and spectral scans of the common femoral, superficial femoral, popliteal, anterior tibial, posterior tibial, and peroneal veins in the longitudinal and transverse planes. Specifically, the vessels were examined for compressibility and intraluminal filling defects on grayscale scans, presence or absence of flow voids on color Doppler scans, and spectral evaluation of blood flow characteristics, which included augmentation with calf vein compression and characterization of the respiratory variation pattern. Lack of luminal obliteration with compression, flow void on color Doppler scan, and abnormal flow detected at spectral analysis were criteria used to determine the presence or absence of thrombus. The presence of echogenic thrombus associated with irregularity of the vein wall, wall thickening, reduced vessel wall diameter, multiple small collaterals, and venous reflux were criteria used to designate a chronic from an acute thrombus. The DVT was noted in one or more of the following positions: iliofemoral vein, common femoral vein, superficial femoral vein, popliteal vein, and calf vein. A patient was classified as having unilateral signs and symptoms of DVT if pain or edema in one extremity was present.
Forty percent (435/1080) of patients presented with unilateral symptoms of lower-extremity DVT. The next most common reasons for ultrasound scan in our cohort were postoperative surveillance and bilateral leg edema. The 435 patients with the unilateral symptoms form the basis of this report. Statistical analysis was performed with the χ 2 test using an SPSS 10.0 statistical software package. JOURNAL OF VASCULAR SURGERY Volume 34, Number 5 Garcia et al 793
The average age of our patients was 58.6 years, and our male-to-female ratio was approximately 1:1; females represented 50.8% of patients studied with unilateral symptoms. Approximately 5.9% of our patients had a history of previous DVT (Table I) .
RESULTS
DVT was diagnosed in 117 (26.9%) patients. The DVT was located ipsilateral to symptoms in 22.1% (96/435), bilaterally in 2.9% (13/435), and in only the contralateral limb in 1.8% (8/435) of patients. Right leg symptoms were present in 228 of the patients and left leg symptoms were present in 207 of the patients. The distribution of ipsilateral, bilateral, and contralateral thrombus were similar between the right and left legs. Contralateral thrombus was present in 1.3% (n = 3) of the right legs and 2.4% (n = 5) of the left legs studied (Table II) .
The 435 patients with unilateral symptoms were then categorized according to inpatient or outpatient status at the time of the ultrasound scan. There were 159 (36.5%) inpatients and 276 (63.4%) outpatients. DVT was identified in 54 (33.9%) of the inpatients and 63 (22.8%) of the outpatients. Thus, an inpatient was more likely than an outpatient to have a DVT if unilateral symptoms were present (P < .05). Of the 117 patients with DVT, 5 (4.2%) were categorized as having chronic DVT. Four of these patients were inpatients, and thrombus localized to the common femoral vein in 2, the superficial femoral vein in 1, and the popliteal vein in 1. A chronic popliteal vein thrombus was noted in one of the outpatients. Thirty-eight (23.8%) ipsilateral DVTs were identified in the inpatient group. Bilateral DVTs occurred in 5.0% of inpatients (n = 8), and contralateral DVTs were identified in 5.0% (n = 8).
Of the outpatients with DVT, 21.0% (n = 58) had ipsilateral thrombus and 1.8% (n = 5) had bilateral thrombi present. No outpatients were found to have thrombosis present in the asymptomatic contralateral limb. Comparing inpatients and outpatients with respect to contralateral DVT, inpatients were significantly more likely to have a contralateral DVT than the outpatients (P < .001).
In the 117 patients found to have DVT, thrombus was noted in 192 locations. The number of thrombi per location were counted, and it was noted that thrombosis occurred in the following locations in decreasing order of frequency: popliteal vein (29%), common femoral vein (27%), superficial femoral vein (20%), iliofemoral vein (19%), and calf veins (5%) (Fig 1) . There were 2 anterior tibial, 5 posterior tibial, and 3 peroneal vein thrombi identified in the group of patients with calf vein DVT. There were no soleus or gastrocnemius vein DVTs noted in our patients.
Asymptomatic contralateral DVT was only identified in the inpatient group. The average age of these eight patients was 69.5 years. Two of 8 patients (25%) were studied during the postoperative period, and 4 of 8 (50%) of these patients had previous DVT. None of the four patients with a history of DVT had previous DVT localized to the asymptomatic contralateral extremity. Five patients had thrombus in the popliteal vein, and three patients had thrombus in the superficial femoral vein. Overall, the group tended to be of high acuity with admission diagnoses of congestive heart failure, metastatic breast cancer, human immunodeficiency virus, unstable angina, pneumonia, and stroke (Table III) . All of the patients, with the exception of the two patients noted to have chronic DVT, were treated with anticoagulation therapy.
DISCUSSION
Venous ultrasound scanning is a noninvasive, relatively inexpensive modality for the diagnosis of DVT, with a reported sensitivity of 93% and specificity of 98%. 9 Widespread acceptance of this technique has potentially lowered the threshold for duplex scanning too far, as few examinations confirm the diagnosis of DVT. 10 Better criteria are necessary to determine who should receive an ultrasound scan and how the study should be performed (unilateral versus bilateral examination). Some authors have identified clinical assessment scoring and D-dimer assays as having significant potential to limit the number of unnecessary duplex scans performed. 11 Other authors have focused on modifying the protocol of the ultrasound scan to increase the efficiency of the vascular laboratory, for example, bilateral versus unilateral examination and the two-point compression evaluation.
Our investigation focusing on unilateral versus bilateral investigation highlights two important clinical observations. First, a duplex scan was more likely to identify a DVT in inpatients with unilateral extremity symptoms when compared with outpatients. Previous authors have identified an increased frequency of DVT in inpatients, but these studies did not focus on patients with unilateral symptoms. 12, 13 Our study is unique in that it shows a difference in the frequency of positive studies between inpatients and outpatients with unilateral symptoms. It is unclear whether this difference holds true for other subpopulations examined for DVT.
Our study also noted no instance of isolated DVT in the contralateral, asymptomatic limb in outpatients. On the other hand, eight inpatients were noted to have isolated DVT contralateral to symptoms. This finding was highly significant (P < .001). We would propose that a negative unilateral ultrasound scan is sufficient in outpatients. If the unilateral study is positive, the opposite leg should then be studied to rule out bilateral thrombotic events (Fig 2) .
Bilateral DVT occurred in 2.9% of our 435 patients and has been reported to occur in 0% to 32% of those studied with unilateral symptoms. 1, 4, 7, 14, 15 This high frequency of bilateral DVTs is the reason that many physicians believe bilateral ultrasound scanning to be necessary in all patients being studied. Many of the proponents of unilateral ultrasound scanning argue that bilateral exam is unnecessary despite this observation because treatment will be unaffected (ie, anticoagulation) whether thrombus is localized to one leg or both legs. However, regardless of the treatment, there is use in knowing a thrombus exists in the contralateral extremity. For example, the physician may wish to counsel the patients about the potential of developing post-thrombotic syndrome in that extremity, or if symptoms subsequently develop in that extremity, it may be useful for treatment decisions to know that this thrombus was previously present.
It is difficult to argue that treatment does not change regardless of findings unless there is a relatively high frequency of isolated contralateral DVTs. Most studies have reported low rates of contralateral DVTs (0%-3.8%) 1-3,7 and, thus, have considered them insignificant. One study reported a contralateral DVT rate of 8.9% and as a result recommended that cancer patients with ipsilateral symptoms undergo bilateral examination. 8 We noted eight inpatients JOURNAL OF VASCULAR SURGERY Volume 34, Number 5 Garcia et al 795 with contralateral DVT in our study. These patients would not have been diagnosed if a unilateral examination protocol had been in effect. Thus, we believe that unilateral ultrasound scanning is not appropriate for inpatients. However, only 5% of all inpatients had asymptomatic contralateral DVT. If patients with a history of DVT had been excluded, the frequency of isolated contralateral DVT would have only been 2.5%. Because the specificity of ultrasound scanning for DVT is 98%, this low incidence of isolated DVT would then be below the accuracy of duplex ultrasound scanning. Therefore, our results do not explicitly preclude unilateral examination for inpatients if other risk factors, such as history of DVT, are considered. In our study, this criterion would have limited the number of potential missed isolated contralateral DVTs if a unilateral examination protocol had been in effect for the inpatient population.
In the patients with DVT, the popliteal vein was involved in 29%, the common femoral vein in 27%, the superficial femoral vein in 20%, and the calf veins in 5% of the patients. Other studies have noted a similar frequency of involvement in the above-the-knee segments of deep vein but have also reported higher rates of calf DVT. 4, 12, 14, 16 It is unclear why so few calf DVTs were identified in our study. Perhaps this low frequency of calf DVT is simply secondary to the population we studied, considering that a higher rate of calf DVT was noted when we included patients with bilateral edema, symptoms suggestive of pulmonary embolism, and postoperative surveillance in our analysis. Approximately 4% of our patients were identified as having chronic DVT; this is consistent with other studies, which have reported a 3% to 7% chronic DVT rate. 2, 4 Differentiating chronic from acute DVT is not always easy and may not be definitive by ultrasound scan. In our study, some of the patients may have been more cautiously diagnosed with acute DVT, whereas in fact they may have truly had a chronic DVT. This may help to account for some of the inpatients with asymptomatic limb DVT. An equal frequency of left-sided and right-sided DVT was noted, and thus a predilection for left-sided DVTs as other have noted 14 was not observed.
This study provides data to support an algorithm that may improve resource use in our vascular laboratories ( Fig  2) . Some studies have noted that the average time for a bilateral ultrasound scan is 28 to 30 minutes. Limiting the examination to a unilateral scan saves approximately 6 minutes of technician time because a significant portion of the time is spent in patient preparation. 4, 6, 17 In our study, only 63 bilateral outpatient studies would have been required. This leaves 217 outpatient examinations that could have been performed as a unilateral study. This may have resulted in nearly 22 hours of technician time available for other studies. Many vascular laboratories currently study only the symptomatic extremity in patients with unilateral symptoms. Blebea et al 18 noted that approximately 75% of accredited vascular laboratories in the United States perform unilateral ultrasound scans in patients with unilateral symptoms. The Intersocietal Commission for Accreditation of Vascular Laboratories does not prohibit such practices and recognizes that unilateral exams "may be appropriate for specific indications." The commission suggests that each laboratory have a protocol for the use of unilateral examinations. 19 There is also a Current Procedural Terminology code for unilateral examinations. In 1995, the code 93971, which had been used to describe a "limited or follow-up study," was modified to describe a "unilateral or limited study." The reimbursement for this code is only one dollar less than the reimbursement for the bilateral study. 4, 17 The findings of our study are limited by its retrospective method and by the fact that the study population represents only 12% of all patients undergoing bilateral ultrasound scanning at our institution during the study period. However, our data suggest that it is safe to perform unilateral ultrasound scans in outpatients with unilateral symptoms and also that unilateral examination in inpatients with unilateral symptoms may not be appropriate. These conclusions were somewhat predictable because one would expect outpatients and inpatients to have different degrees of risk for DVT, considering that risk factors for outpatients may be somewhat different than for the inpatient population.
Dr Joann M. Lohr (Cincinnati, Oh) . This manuscript once again raises the issue of unilateral venous scanning in a specific subgroup. This is a retrospective review suffering from "randomized selected patient population" instead of consecutive data analysis. From your presentation it appears that you did include all patients who had unilateral symptoms, but your manuscript stated otherwise.
Traditional risk factors for DVT were not evaluated in the expanded abstract that I received. In fact, comorbidity and acuity were referred to with HIV and pneumonia being listed. I am not sure this analysis is valid as the presence of varicose veins, chronic venous insufficiency, estrogen use, pregnancy, postoperative status, hypercoagulable states, trauma, immobility, and previous SVT were not evaluated. Of the 117 patients with thrombi, 22 patients in this report actually had bilateral thrombosis. In the 435 patients analyzed initially, 63 were outpatients with thrombosis identified. Of the 273 outpatient studies that you reviewed, this does show a low prevalence of thrombosis in the outpatient group. The authors then propose that if DVT is found as an outpatient we should proceed to bilateral scanning. They suggest an algorithm that is developed to save technologists time and improve vascular laboratory efficiency. Unfortunately, we have centralized computerized
scheduling where carotid and venous disease are like a foreign language to the registration clerk. Patients are frequently scheduled incorrectly. How would you propose to set up the laboratory to allow unilateral scanning? Surely you would not expect the registration clerk to ask the screening questions and pick the correct procedure. How much time does scanning the second limb add to your scanning? Remember, patients will have to give a history, answer questions, undress, be scanned, turn over, and redress for either unilateral or bilateral scan. This raises another issue I have with this paper, which is the very low incidence of calf vein thrombi. These results are much different than our previously reported incidence of calf vein thrombosis. In 90% of your patients the scan evaluated was from the groin to the ankle. However, in 10% of the studies, the involved veins were from the groin to the knee. How and who determined which veins were evaluated? Do you have several scanning protocols in effect? Pain, edema, and erythema and cellulitis were listed in your manuscript as symptoms. Unfortunately cellulitis is not a symptom. The presence of discoloration, tenderness, ulceration, and palpable masses was not recorded or evaluated. Of the outpatients with DVT, five had bilateral thrombosis. The incidence was found to be higher in the inpatient population, and the authors state that bilateral scanning is justified in inpatients and also possibly in outpatients with a history of malignancy.
I disagree with the statement the authors have in the manuscript which states, "our paper is unique in that it shows a difference in the frequency of positive studies between inpatients and outpatients with unilateral symptoms." This has been discussed at this meeting previously by both Dr Blebea and myself.
Unfortunately, just because we can do something does not mean we should. In a claudicator with unilateral symptoms, would we only do ABIs on one limb? This paper does not prove the utility of unilateral scanning to improve vascular laboratory efficiency or potentially save the technologist's time.
I would like to thank the Society for the privilege of discussing this manuscript.
Dr Nicholas D. Garcia. Thank you very much, Dr Lohr, for your insightful comments and your excellent questions.
Your first question, "how much time does it take to scan the opposite extremity?" We actually did not time how long it takes to scan the opposite extremity, but there is literature out thereone paper from Dr Blebea-that looked at that, and they determined that it takes about 28 to 30 minutes to do both extremities, and the time it takes to do the second extremity is only about 6 minutes, as most of the time spent with this study is in patient preparation. If you look at our study, if we did save those 6 minutes for each patient reasonably receiving a unilateral scan, approximately 217 outpatients, this would have resulted in about 22 hours of saved technician time.
Your other question, relating to saved technician time, is a good question. I think there do remain problems with scheduling, and I think just because you potentially have 6 minutes of saved technician time that this does not automatically translate into time available for other studies. We would hope that the technician would finish the exam and then move on to another study, but we understand that this will probably not happen in most cases.
Your point about the calf veins and having a low incidence of calf veins in our study. We did note a lower rate than other authors have reported. This is potentially due to the fact that only about 90% of the asymptomatic extremities had their tibial vessels examined. Also, most authors studying DVT have not reported calf DVT in patients with only unilateral symptoms. However, the main reason for this low level of calf DVT is unclear. When we looked at our larger group of 1080 patients, not just the patients with unilateral symptoms, we did note a higher frequency of calf DVT-still not as high as others, but around 20% to 25%.
Finally, we do recognize that other authors have shown that inpatients do have a higher frequency of DVT when compared to outpatients. Our point was not to say that we were unique in this; our point was that the authors that have shown this difference have utilized a wider variety of patients, ie, they have also included patients for rule-out PE protocol and also patients for postoperative surveillance in their studies, and our study just looks at patients with unilateral symptoms.
Thank you. Dr John Blebea (Hershey, Penn). I enjoyed your presentation, especially since your conclusions agree with those of our prior studies, and congratulate you on a great study. I have a couple of comments and questions.
In our study, we actually looked at both inpatients and outpatients and did not find a difference among these two groups. We did find a small minority of patients with contralateral deep venous thrombosis in unilaterally symptomatic patients. However, in our experience with approximately 250 patients, all of those contralateral proximal DVTs were chronic and were not acute. We therefore felt comfortable that, even if they had not been detected, this would not have changed any therapeutic interventions. My first question is, how comfortable are you that, in those patients in which the unilateral symptomatic leg was completely normal, the contralateral DVT was actually acute and not chronic? This is particularly important because your DVTs were proximal while we usually found contralateral isolated DVT to be distal, so their clinical significance and diagnostic accuracy can be questioned.
Secondly, I have a question about sensitivity and specificity. As vascular surgeons, we are all justly proud of our vascular laboratories and technologists, but I think we also have to be realistic and keep in mind that there are going to be some false-positive results. Especially in the present era, when we have very few confirmatory venograms, if we find a contralateral asymptomatic DVT, we need to put it into the clinical context and ask ourselves if it is a real DVT or a false-positive DVT.
Finally, in addressing Dr Lohr's comments, I do not believe that it is appropriate for the vascular technologist or the laboratory secretary or the interpreting physician to determine if the patient is symptomatic in just one leg or two legs and therefore decide if this will be a unilateral or a bilateral examination. The ordering physician needs to make this clinical decision when patients are initially referred to the vascular laboratory. We utilize a request form on which the requesting physician indicates whether the patient has a unilateral or a bilateral symptomatic limb and on this basis decide whether a unilateral or bilateral study is to be performed.
Thank you for your excellent work. Dr Garcia. Thank you, Dr Blebea. I have enjoyed reading your papers.
The first question is how comfortable are we that the limb with isolated contralateral DVT was truly asymptomatic. Again, we understand the limitations of the retrospective nature of this paper, but these patients were specifically rereviewed when we found these, and there was no mention or observations in the charts that these limbs had any abnormalities. We are pretty confident that these limbs were normal. Six of eight patients with isolated contralateral DVT had acute DVT.
The question with respect to the false-negative and falsepositive aspects of this study cannot be answered using the available data. You would need to compare ultrasound with venography in order to answer this better.
Finally, I agree with you, in that I think a protocol whereby the referring physician decides unilateral or bilateral is a good idea and could be helpful in eliminating some of the problems raised by Dr Lohr.
Thank you very much.
